|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit/(loss) before tax | |||
| Adjustments for non-cash items | |||
| Depreciation, amortisation and impairment | |||
| Net loss/(gain) from investing activities | |||
| Share of (profit)/loss in associates and joint ventures | |||
| Change in expected credit losses gross of recoveries and other credit impairment charges | |||
| Provisions including pensions | |||
| Share-based payment expense | |||
| Other non-cash items included in profit/(loss) before tax | |||
| Elimination of exchange differences | |||
| Changes in operating assets and liabilities | |||
| – change in net trading securities and derivatives | |||
| – change in loans and advances to banks and customers | |||
| – change in reverse repurchase agreements – non-trading | |||
| – change in financial assets designated and otherwise mandatorily measured at fair value | |||
| – change in other assets | |||
| – change in deposits by banks and customer accounts | |||
| – change in repurchase agreements – non-trading | |||
| – change in debt securities in issue | |||
| – change in financial liabilities designated at fair value | |||
| – change in other liabilities | |||
| – dividend received from associates | |||
| – contributions paid to defined benefit plans | |||
| – tax (paid)/received | |||
| Net cash from operating activities | |||
| Cash flows from investing activities | |||
| – purchase of financial investments | |||
| – proceeds from the sale and maturity of financial investments | |||
| – net cash flows from the purchase and sale of property, plant and equipment | |||
| – net investment in intangible assets | |||
| – net cash outflow from investment in associates and acquisition of businesses and subsidiaries | |||
| – net cash flow on disposal of subsidiaries, businesses, associates and joint ventures | |||
| Net cash from investing activities | |||
| Cash flows from financing activities | |||
| – issue of ordinary share capital and other equity instruments | |||
| – redemption of other equity instruments | |||
| - subordinated loan capital issued | |||
| – subordinated loan capital repaid | |||
| – dividends to the parent company | |||
| – funds received from the parent company | |||
| – dividends paid to non-controlling interests | |||
| Net cash from financing activities | |||
| Net increase in cash and cash equivalents | |||
| Cash and cash equivalents at 1 Jan | |||
| Exchange difference in respect of cash and cash equivalents | |||
| Cash and cash equivalents at 31 Dec | |||
| Cash and cash equivalents comprise of | |||
| – cash and balances at central banks | |||
| – items in the course of collection from other banks | |||
| – loans and advances to banks of one month or less | |||
| – reverse repurchase agreement with banks of one month or less | |||
| – treasury bills, other bills and certificates of deposit less than three months | |||
| – cash collateral, net settlement accounts and items in course of collection from/transmission to other banks | |||
| - cash and cash equivalents held for sale | |||
| Items in the course of transmission to other banks |
Loading...
